Global Lactose Intolerance Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Lactose Intolerance Market Research Report 2024
Lactose intolerance is a gastrointestinal condition developed in patients with a low activity level of the lactase enzyme. Lactase is responsible for breakdown of lactose, a type of sugar found in all dairy products. Symptoms of lactose intolerance are at times very painful and even embarrassing due to flatulence. Symptoms are usually seen only after consumption of dairy products. They include abdominal pain, flatulence, bloating, cramps, and diarrhea. In a study on lactose intolerance conducted by Engage Health in 2008, 82% of patients reported that symptoms of lactose intolerance affect their daily social routine.
According to MRAResearch’s new survey, global Lactose Intolerance market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lactose Intolerance market research.
Key companies engaged in the Lactose Intolerance industry include Johnson & Johnson, National Enzyme Company, Vetbiochem India, Ganeden Biotech, Ritter Pharmaceuticals, McNeil Nutritionals, Gelda Scientific, Guardian Drug Company and Deerland Enzymes, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Lactose Intolerance were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Lactose Intolerance market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Lactose Intolerance market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Johnson & Johnson
National Enzyme Company
Vetbiochem India
Ganeden Biotech
Ritter Pharmaceuticals
McNeil Nutritionals
Gelda Scientific
Guardian Drug Company
Deerland Enzymes
Roche Diagnostics.
Segment by Type
Food Supplements
Enzymatic Lactase Supplements
Others
Hospitals and Clinics
Home Care
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Lactose Intolerance report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Lactose Intolerance market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lactose Intolerance market research.
Key companies engaged in the Lactose Intolerance industry include Johnson & Johnson, National Enzyme Company, Vetbiochem India, Ganeden Biotech, Ritter Pharmaceuticals, McNeil Nutritionals, Gelda Scientific, Guardian Drug Company and Deerland Enzymes, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Lactose Intolerance were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Lactose Intolerance market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Lactose Intolerance market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Johnson & Johnson
National Enzyme Company
Vetbiochem India
Ganeden Biotech
Ritter Pharmaceuticals
McNeil Nutritionals
Gelda Scientific
Guardian Drug Company
Deerland Enzymes
Roche Diagnostics.
Segment by Type
Food Supplements
Enzymatic Lactase Supplements
Others
Segment by Application
Hospitals and Clinics
Home Care
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Lactose Intolerance report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source